+++
title = "FDA clears 1st fecal transplant treatment for gut infection"
description = "WASHINGTON (AP) — U.S. officials have approved the first pharmaceutical-grade version of the so-called fecal transplant procedures that doctors have increasingly used against hard-to-treat intestinal infections."
date = "2022-12-01 12:45:44"
slug = "6388a1d5f495686e1b162cce"
image = "https://i.imgur.com/GPP6dVm.jpg"
score = "1783"
categories = ['procedures', 'fda', 'transplant']
+++

WASHINGTON (AP) — U.S. officials have approved the first pharmaceutical-grade version of the so-called fecal transplant procedures that doctors have increasingly used against hard-to-treat intestinal infections.

## Highlights

- The Food and Drug Administration on Wednesday approved Rebyota for adults who have trouble fighting off infections with Clostridium difficile, commonly referred to as C. difficiles.
- The new therapy from Ferring Pharmaceuticals Inc.
- is manufactured at a facility in Minnesota from stool donations that are screened for dozens of infections and viruses.
- The therapy is delivered via the rectum by health professionals as a one-time procedure.
- The treatment is only for patients who have already taken a course of antibiotics for recurrent infection.
- The infection is particularly dangerous when it reoccurs and is linked to about 15,000 to 30,000 deaths a year.

---

{{< rawhtml >}}
  <p class="article-category">
    <a target="_blank" href="https://apnews.com/article/health-business-philanthropy-80e3d3737293482332fccaf1a5244260">READ THE ORIGINAL ARTICLE</a>
  </p>
{{< /rawhtml >}}
